MIRA INFORM REPORT

 

 

 

Report Date :           

15.03.2012

 

IDENTIFICATION DETAILS

 

Correct Name :

EMS S.A. 

 

 

Registered Office :

Rodovia SP 101, Hortoladia, 13186

 

 

Country :

Brazil

 

 

Date of Incorporation :

Not Available

 

 

Legal Form :

Private Independent Company

 

 

Line of Business :

development of products for improvement of health and well being of the population

 

 

No. of Employees :

2,000

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Brazil

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name & address

 

Ems S.A.

Rodovia SP 101

Hortoladia, 13186

Brazil

Tel:       551938879800

Fax:      551938879515

Web:    www.ems.com.br

 

 

synthesis

 

Employees:                  2,000

Company Type:            Private Independent

Financials in:                 USD (Millions)

Reporting Currency:       US Dollar

Annual Sales:               903.6

Total Assets:                 NA

 

 

Business Description

 

EMS S.A. (EMS) is a pharmaceutical company, which is engaged in the development of products for improvement of health and well being of the population. EMS operates two industrial plants in Sao Bernardo do Campo and Hortolandia, Sao Paulo. EMS has a portfolio of over 1,400 products. The company classifies its business into EMS Similar, EMS Genericos, EMS Sigma Pharma, EMS Hospital and EMS Consumption divisions. EMS Sigma Pharma's product portfolio includes antianemics, analgesics, antibiotics, anti-inflammatories, antihypertensive, immunosuppressants and contraceptives. EMS Hospital sells 27 products to hospitals, clinics and health agencies. EMS Consumption manufactures and sells over the counter drugs. EMS is ISO 9001 and ISO 140001 certified. It focuses on the research and development (R&D) activities to develop benzodiazepines diazepam, lorazepam and bromazepam sedative drugs and neurological products. The company is headquartered in Hortolandia, Brazil.

 

Industry             

Industry            Miscellaneous Transportation

ANZSIC 2006:    8520 - Pathology and Diagnostic Imaging Services

NACE 2002:      8514 - Other human health activities

NAICS 2002:     621512 - Diagnostic Imaging Centers

UK SIC 2003:    8514 - Other human health activities

US SIC 1987:    8071 - Medical Laboratories

 

 

Key Executives   

 

Name

Title

Luiz Borgonovi Carlos

President

Carlos Eduardo Sanchez

Presidente

Ana Silvia

Directora de Recursos Humanos

 

 

Corporate Overview

 

Location

Rodovia SP 101

Hortoladia, 13186

Brazil

Tel:       551938879800

Fax:      551938879515

Web:    www.ems.com.br

           

Sales USD(mil):             903.6

Assets USD(mil):           NA

Employees:                   2,000

Industry:                        Miscellaneous Transportation

Company Type:             Private Independent

Quoted Status:              Not Quoted

President:                     Luiz Borgonovi Carlos

 

Contents

·         Industry Codes

·         Business Description

·         Financial Data

 

Industry Codes

 

ANZSIC 2006 Codes:

8520     -          Pathology and Diagnostic Imaging Services

 

NACE 2002 Codes:

8514     -          Other human health activities

 

NAICS 2002 Codes:

621512  -          Diagnostic Imaging Centers

 

US SIC 1987:

8071     -          Medical Laboratories

 

UK SIC 2003:

8514     -          Other human health activities

 

Business Description

EMS S.A. (EMS) is a pharmaceutical company, which is engaged in the development of products for improvement of health and well being of the population. EMS operates two industrial plants in Sao Bernardo do Campo and Hortolandia, Sao Paulo. EMS has a portfolio of over 1,400 products. The company classifies its business into EMS Similar, EMS Genericos, EMS Sigma Pharma, EMS Hospital and EMS Consumption divisions. EMS Sigma Pharma's product portfolio includes antianemics, analgesics, antibiotics, anti-inflammatories, antihypertensive, immunosuppressants and contraceptives. EMS Hospital sells 27 products to hospitals, clinics and health agencies. EMS Consumption manufactures and sells over the counter drugs. EMS is ISO 9001 and ISO 140001 certified. It focuses on the research and development (R&D) activities to develop benzodiazepines diazepam, lorazepam and bromazepam sedative drugs and neurological products. The company is headquartered in Hortolandia, Brazil.

 

More Business Descriptions

Medical Products Laboratory

 

Financial Data

Financials in:

USD(mil)

 

Revenue:

903.6

1 Year Growth

NA

 

 

 

Competitors Report

Company Name

Location

Employees

Ownership

Biotecnica Industria E Comercio Ltda

Varginha . Mg, Brazil

 

Private

Ems Sigma Pharma

Hortolândia, SP, Brazil

4,500

Private

Intrials Research Clinical.

Sao Paulo, Brazil

 

Private

Laboratorio Teuto Brasileiro

Anápolis, GO, Brazil

1,572

Private

Moksha8 Pharmaceuticals, Inc.

Sao Paulo, Brazil

200

Private

 

 

Executive report

 

Executives

 

Name

Title

Function

 

Luiz Borgonovi Carlos

 

President

President

 

Carlos Eduardo Sanchez

 

Presidente

President

 

Ana Silvia

 

Directora de Recursos Humanos

Human Resources Executive

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.49.90

UK Pound

1

Rs.78.15

Euro

1

Rs.65.09

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.